The Pharmacology of Foot Dystonia in Parkinsonism
Abstract
University Clinic for Neurology, Innsbruck, Austria and *The National Hospital for Nervous Diseases, London, England
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In reports by Poewe and colleagues, the most frequent site for off dystonia is the foot, whereas in peak dose dystonia neck and face are more commonly involved.
“In reports by Poewe and colleagues, the most frequent site for off dystonia is the foot, whereas in peak dose dystonia neck and face are more commonly involved (Poewe and Lees 1987;Poewe et al. 1988).”
From The clinical symptoms of Parkinson's disease. (2016) · cites this paper as Poewe and Lees 1987
Cited by
Sorted by citations
The clinical symptoms of Parkinson's disease.
Sveinbjornsdottir, S. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13691 · Cited by 1,410 · see citing works
Dystonia in Parkinson’s disease
Tolosa, E., & Compta, Y. (2006) · Journal of Neurology · doi:10.1007/s00415-006-7003-6 · Cited by 176 · see citing works
Jankovic, J., & Tintner, R. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(01)00025-6 · Cited by 135 · see citing works
- Authors
- Poewe, W. H., & Lees, A. J.
- Venue
- Clinical Neuropharmacology
- Published
- 1987-02
- Volume
- 10
- Issue
- 1
- Pages
- 47-56
- ISSN
- 0362-5664 (ISSN-L)
- OpenAlex
- W2002106653
- Cited by
- 28
- References
- 0
- Citations by year
- 2024: 1 · 2020: 1 · 2017: 1 · 2016: 4 · 2012: 1
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Neuropharmacology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Neurology › Neurological disorders and treatments
- Health Sciences › Medicine › Neurology › Botulinum Toxin and Related Neurological Disorders
- Keywords
- foot dystonia, parkinsonism, pharmacology, antiparkinsonian drugs, dystonia treatment
- MeSH terms
- Dystonia, Foot Diseases, Humans, Levodopa, Parkinson Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
